Related references
Note: Only part of the references are listed.Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Anterior tibialis cmap amplitude correlations with impairment in CMT1A
Kelsey Komyathy et al.
MUSCLE & NERVE (2013)
Power failure: why small sample size undermines the reliability of neuroscience
Katherine S. Button et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population
Burkhard Gess et al.
NEUROMUSCULAR DISORDERS (2013)
High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A Results of a Randomized, Double-Masked, Controlled Trial
Richard A. Lewis et al.
JAMA NEUROLOGY (2013)
Charcot-Marie-Tooth disease in Northern England
Charlotte Foley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Update on Charcot-Marie-Tooth Disease
Agnes Patzko et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Inherited Neuropathies
Angelo Schenone et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Sodium-Dependent Vitamin C Transporter 2 Deficiency Causes Hypomyelination and Extracellular Matrix Defects in the Peripheral Nervous System
Burkhard Gess et al.
JOURNAL OF NEUROSCIENCE (2011)
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease
Sinead M. Murphy et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
Davide Pareyson et al.
LANCET NEUROLOGY (2011)
NETWORKING FOR NEW DRUGS
Claire Ainsworth
NATURE MEDICINE (2011)
168th ENMC International Workshop: Outcome measures and clinical trials in Charcot–Marie–Tooth disease (CMT)
M.M. Reilly et al.
NEUROMUSCULAR DISORDERS (2010)
Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients
C. Toth
ACTA NEUROLOGICA SCANDINAVICA (2009)
Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
Camiel Verhamme et al.
BMC MEDICINE (2009)
The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study
Camiel Verhamme et al.
BRAIN (2009)
Peripheral mechanisms of opioid analgesia
Christoph Stein et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial
Joshua Burns et al.
LANCET NEUROLOGY (2009)
Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randornised, double-blind, placebo-control led trial
Joelle Micallef et al.
LANCET NEUROLOGY (2009)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Relationship between clinical examination, Quality of Life, disability and depression in CMT patients: Italian Multicenter study
L. Padua et al.
NEUROLOGICAL SCIENCES (2008)
Neuropathy progression in Charcot-Marie-Tooth disease type 1A
M. E. Shy et al.
NEUROLOGY (2008)
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease
A. Solari et al.
NEUROMUSCULAR DISORDERS (2008)
Development of a french isometric strength normative database for adults using quantitative muscle testing
Jean-Yves Hogrel et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2007)
Ascorbic acid inhibits PMP22 expression by reducing cAMP levels
Ferdinand Kaya et al.
NEUROMUSCULAR DISORDERS (2007)
A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale
R. C. Graham et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
GABA receptor-mediated effects in the peripheral nervous system - A cross-interaction with neuroactive steroids
V Magnaghi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Reliability and validity of the CMT neuropathy score as a measure of disability
ME Shy et al.
NEUROLOGY (2005)
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
E Passage et al.
NATURE MEDICINE (2004)
Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia
C Verhamme et al.
JOURNAL OF NEUROLOGY (2004)
Share Paper
